Comments
Drug firm Indoco Remedies on Wednesday reported a consolidated net profit of Rs 7.81 crore for the quarter ended September 30.
The company had posted a net loss of Rs 7.45 crore for the corresponding period of the previous fiscal, Indoco Remedies said in a filing to BSE. Consolidated revenue from operations of the company stood at Rs 286.21 crore for the quarter under consideration. It was Rs 236.26 crore for the same period year ago.
“During the second quarter, the company’s India business saw double digit growth at 17.2 per cent... Sequentially, India business has grown by 15.3 per cent, which indicates good momentum,” Indoco Remedies MD Aditi Panandikar said.
On the international business front, with the regulatory challenges easing out, the business in Europe will now take off from here onwards, she added. Shares of Indoco Remedies were trading at Rs 168 per scrip on BSE, up 9.09 per cent from their previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.